We have read with interest the recently published article by Nikas et al. on periprocedural adverse events (PAEs) of carotid artery stenting (CAS) with use of the GORE Flow Reversal System. In light of this data, we would like to share our own single-center experience with transcranial doppler monitoring (TCD) during proximally protected CAS using MO.MA Cerebral Protectin Device.
At first, however, several important points should be emphasized.